Raia Drogasil S.A. RADLY
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 14.28% | 23.17% | 26.71% | 29.78% | 7.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.28% | 23.17% | 26.71% | 29.78% | 7.85% |
| Cost of Revenue | 10.17% | 19.06% | 23.64% | 30.17% | 6.23% |
| Gross Profit | 23.49% | 32.27% | 33.72% | 28.86% | 11.69% |
| SG&A Expenses | 23.66% | 31.29% | 28.91% | 23.65% | 10.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 666.38% | 630.73% | 914.80% | -- | -- |
| Total Operating Expenses | 13.86% | 22.30% | 27.87% | 28.49% | 7.37% |
| Operating Income | 19.98% | 34.93% | 5.49% | 53.17% | 14.88% |
| Income Before Tax | 17.33% | 57.84% | -14.81% | 16.30% | 4.48% |
| Income Tax Expenses | 18.34% | 142.95% | -198.25% | 120.08% | -17.06% |
| Earnings from Continuing Operations | 17.10% | 44.02% | 15.05% | -10.22% | 10.94% |
| Earnings from Discontinued Operations | -100.02% | -84.19% | -42.94% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | 12,761.84% | -91.34% |
| Net Income | -4.70% | 27.33% | 7.78% | -5.81% | 37.98% |
| EBIT | 19.98% | 34.93% | 5.49% | 53.17% | 14.88% |
| EBITDA | 21.01% | 30.63% | 10.20% | 54.64% | 13.05% |
| EPS Basic | -2.82% | 29.77% | 9.58% | 2.53% | 38.16% |
| Normalized Basic EPS | 41.76% | 61.09% | -25.00% | 39.71% | -1.14% |
| EPS Diluted | -3.25% | 28.39% | 7.23% | 2.25% | 37.82% |
| Normalized Diluted EPS | 40.93% | 61.28% | -26.61% | 39.22% | -1.52% |
| Average Basic Shares Outstanding | -1.93% | -1.96% | -1.89% | -7.96% | -0.10% |
| Average Diluted Shares Outstanding | -1.41% | -1.96% | 0.33% | -7.72% | 0.11% |
| Dividend Per Share | -- | -- | -- | -- | -34.80% |
| Payout Ratio | -- | -0.30% | 3.96% | 0.68% | -0.95% |